Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nls Pharmaceutics Ltd (NQ: NLSP ) 0.2040 +0.0130 (+6.81%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nls Pharmaceutics Ltd < Previous 1 2 3 4 5 6 7 Next > NLS Pharmaceutics Announces Registered Direct Offering June 28, 2024 Via ACCESSWIRE NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments June 27, 2024 Via ACCESSWIRE Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements June 25, 2024 Via ACCESSWIRE PLTR Stock: Palantir Bags New Partnership With ARPA-H for AI/ML June 20, 2024 Palantir stock is on the rise Thursday as PLTR investors react to a new $19 million contract for the big data and AI company. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Why Is NLS Pharmaceutics (NLSP) Stock Up 163% Today? June 18, 2024 NLS Pharmaceutics stock is up on Tuesday with heavy trading of NLSP shares despite a lack of news from the company this morning. Via InvestorPlace Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga Dow Edges Lower; US Current Account Deficit Widens In Q1 June 20, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Is NLS Pharmaceutics (NLSP) Stock Down 23% Today? June 20, 2024 NLS Pharmaceutics stock is down on Thursday as shares of NLSP come off of a recent rally that was fueled by heavy trading on Tuesday. Via InvestorPlace Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket June 20, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday June 20, 2024 Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements this morning! Via InvestorPlace Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 18, 2024 Via Benzinga US Stocks Mixed; Retail Sales Increase 0.1% In May June 18, 2024 Via Benzinga Why Is Quantum (QMCO) Stock Down 32% Today? June 18, 2024 Quantum stock is down on Tuesday as investors in QMCO shares react to the company's earnings report for fiscal 2024 this morning. Via InvestorPlace Why Is Aerwins Technologies (AWIN) Stock Down 54% Today? June 18, 2024 Aerwins Technologies stock is falling hard on Tuesday as investors in AWIN shares prepare for them to be delisted this morning. Via InvestorPlace Why Is Actelis Networks (ASNS) Stock Up 144% Today? June 18, 2024 Actelis Networks stock is up with heavy trading of ASNS shares after signing Carahsoft Technology as a new supply partner. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 18, 2024 It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning! Via InvestorPlace Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket June 18, 2024 Via Benzinga NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA) June 11, 2024 Via ACCESSWIRE NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects in Narcoleptic-like Rat Model May 28, 2024 Via ACCESSWIRE NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from Nasdaq May 24, 2024 Via ACCESSWIRE NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing April 19, 2024 Via ACCESSWIRE NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering March 22, 2024 Via ACCESSWIRE NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering March 20, 2024 Via ACCESSWIRE NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform March 20, 2024 Via ACCESSWIRE NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event March 14, 2024 Via ACCESSWIRE Nasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing Compliance March 11, 2024 Via ACCESSWIRE NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq February 23, 2024 Via ACCESSWIRE Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday January 29, 2024 It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning! Via InvestorPlace Notice of Deficiency with Nasdaq Continued Listing Requirements January 12, 2024 Via ACCESSWIRE NLS Pharmaceutics CEO Issues Letter to Shareholders December 29, 2023 Via ACCESSWIRE < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
